These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
941 related items for PubMed ID: 26113478
1. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey. Sabouret P, Bricard M, Hermann MA, Cotté FE, Deret-Bixio L, Rushton-Smith S. Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478 [Abstract] [Full Text] [Related]
2. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G. Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406 [Abstract] [Full Text] [Related]
3. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey. Brandes A, Overgaard M, Plauborg L, Dehlendorff C, Lyck F, Peulicke J, Poulsen SV, Husted S. Clin Cardiol; 2013 Jul; 36(7):427-32. PubMed ID: 23670894 [Abstract] [Full Text] [Related]
4. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP. Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [Abstract] [Full Text] [Related]
5. Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database. Sabouret P, Depret-Bixio L, Cotte FE, Marie P, Bedira N, Blin P. Clin Res Cardiol; 2014 Nov; 103(11):887-93. PubMed ID: 24830515 [Abstract] [Full Text] [Related]
6. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan. Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH. Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379 [Abstract] [Full Text] [Related]
7. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort. Huisman MV, Ma CS, Diener HC, Dubner SJ, Halperin JL, Rothman KJ, Teutsch C, Schoof N, Kleine E, Bartels DB, Lip GY, GLORIA-AF Investigators. Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063 [Abstract] [Full Text] [Related]
8. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation. Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL. Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115 [Abstract] [Full Text] [Related]
9. Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study. Ermini G, Perrone V, Veronesi C, Degli Esposti L, Di Pasquale G. Vasc Health Risk Manag; 2017 Mar; 13():239-246. PubMed ID: 28740396 [Abstract] [Full Text] [Related]
10. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey. Potpara TS, Lenarczyk R, Larsen TB, Deharo JC, Chen J, Dagres N, Conducted by the Scientific Initiatives Committee, European Heart Rhythm Association. Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617 [Abstract] [Full Text] [Related]
11. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey. Dan GA, Iliodromitis K, Scherr D, Marín F, Lenarczyk R, Estner HL, Kostkiewicz M, Dagres N, Lip GYH. Europace; 2018 Aug 01; 20(8):1382-1387. PubMed ID: 29893840 [Abstract] [Full Text] [Related]
12. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice. Bajorek B, Magin PJ, Hilmer S, Krass I. J Clin Pharm Ther; 2016 Aug 01; 41(4):432-40. PubMed ID: 27338004 [Abstract] [Full Text] [Related]
17. Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice. Osseby GV, Benatru I, Sochurkova D, Urbinelli R, Megherbi SE, Couvreur G, Moreau T, Wolf J, Giroud M. Prev Med; 2004 Feb 10; 38(2):121-8. PubMed ID: 14715203 [Abstract] [Full Text] [Related]
19. Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II. Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma C, Zint K, Elsaesser A, Bartels DB, Lip GY, GLORIA-AF Investigators. Am J Med; 2015 Dec 10; 128(12):1306-13.e1. PubMed ID: 26239094 [Abstract] [Full Text] [Related]
20. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA). Potpara TS, Larsen TB, Deharo JC, Rossvoll O, Dagres N, Todd D, Pison L, Proclemer A, Purefellner H, Blomström-Lundqvist C, Scientific Initiatives Committee of European Heart Rhythm Association (EHRA). Europace; 2015 Jun 10; 17(6):986-93. PubMed ID: 26023177 [Abstract] [Full Text] [Related] Page: [Next] [New Search]